Exponent (NASDAQ:EXPO - Get Free Report) will likely be issuing its Q2 2025 quarterly earnings data after the market closes on Thursday, July 31st. Analysts expect the company to announce earnings of $0.48 per share and revenue of $130.82 million for the quarter.
Exponent (NASDAQ:EXPO - Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The business services provider reported $0.52 earnings per share for the quarter, topping the consensus estimate of $0.48 by $0.04. The business had revenue of $137.44 million during the quarter, compared to the consensus estimate of $134.63 million. Exponent had a return on equity of 25.33% and a net margin of 18.87%. The firm's revenue for the quarter was up .2% compared to the same quarter last year. During the same period in the prior year, the company posted $0.59 EPS. On average, analysts expect Exponent to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.
Exponent Stock Performance
Shares of Exponent stock traded down $1.55 on Friday, hitting $72.51. 258,694 shares of the company traded hands, compared to its average volume of 263,214. Exponent has a 52 week low of $71.72 and a 52 week high of $115.75. The business has a 50-day simple moving average of $76.34 and a 200 day simple moving average of $81.68. The stock has a market capitalization of $3.68 billion, a P/E ratio of 35.37 and a beta of 0.90.
Exponent Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Friday, June 20th. Investors of record on Friday, June 6th were paid a dividend of $0.30 per share. The ex-dividend date of this dividend was Friday, June 6th. This represents a $1.20 annualized dividend and a yield of 1.65%. Exponent's payout ratio is 58.54%.
Insiders Place Their Bets
In other Exponent news, VP Joseph Rakow sold 1,573 shares of the stock in a transaction dated Tuesday, May 27th. The shares were sold at an average price of $77.72, for a total transaction of $122,253.56. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, VP John Pye sold 2,000 shares of the business's stock in a transaction dated Friday, May 23rd. The stock was sold at an average price of $76.32, for a total value of $152,640.00. Following the completion of the sale, the vice president owned 29,204 shares in the company, valued at $2,228,849.28. This represents a 6.41% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 6,267 shares of company stock worth $489,120 in the last 90 days. 1.60% of the stock is currently owned by corporate insiders.
Institutional Trading of Exponent
A hedge fund recently bought a new stake in Exponent stock. United Services Automobile Association purchased a new stake in Exponent, Inc. (NASDAQ:EXPO - Free Report) in the first quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 3,282 shares of the business services provider's stock, valued at approximately $270,000. Institutional investors and hedge funds own 92.37% of the company's stock.
Exponent Company Profile
(
Get Free Report)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Featured Articles

Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.